IXICO Plc (IXI):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:IXICO Plc (IXI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7479
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints and assessing the safety and efficacy of drugs. The company offers products such as assessa, trial tracker, trialwire and mehealth. It provides web-based platform to transfer data, web-based system to track imaging-based research study or clinical trial in real time, medical device for clinical diagnosis of dementia, and others. The company’s mehealth is a secure online software for clinicians to support evidence-based decision making and improve the monitoring and treatment of patients. IXICO is headquartered in London, the UK.

IXICO Plc (IXI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IXICO Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
IXICO Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
IXICO Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
IXICO Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
IXICO Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
IXICO Plc, Medical Equipment, Deal Details 10
Partnerships 10
IXICO Enters into Agreement with Pharma Company 10
Equity Offering 11
Ixico to Raise USD7.5 Million in Private Placement of Shares 11
Acquisition 12
Ixico Acquires Optimal Medicine for USD2.3 Million 12
IXICO Plc – Key Competitors 13
IXICO Plc – Key Employees 14
IXICO Plc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Financial Announcements 16
May 22, 2018: IXICO: Half Yearly Report to 31 March 2018 16
Dec 11, 2017: IXICO: Financial Results for the year ended 30 September 2017 17
May 22, 2017: IXICO: Half Yearly Report to 31 March 2017 18
Corporate Communications 19
Jan 22, 2018: AGM Statement and Board Changes 19
Jan 17, 2017: IXICO appoints Giulio Cerroni as Chief Executive Officer 20
Product News 21
Mar 10, 2017: IXICO presents novel sleep measurement technology at a workshop on Mobile Devices for Clinical Trials in Neurological Diseases in Arizona, US. 21
Other Significant Developments 22
Sep 11, 2018: Significant new contract with a top 10 global pharmaceutical company to provide specialist medical imaging services for a Phase III Huntington’s disease clinical trial 22
Aug 21, 2018: IXICO: Trading update for the financial year ending 30 September 2018 23
Nov 28, 2017: IXICO: Strategic and Operational Update 24
Oct 04, 2017: IXICO signs new contract to deploy biosensors in a Phase II neurological clinical trial 26
Sep 25, 2017: IXICO to provide specialist MR and PET imaging services in Phase II Huntington’s disease clinical trial 27
Jul 18, 2017: IXICO hosts Alzheimer Expert Symposium 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
IXICO Plc, Medical Equipment, Key Facts, 2017 2
IXICO Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
IXICO Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
IXICO Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
IXICO Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
IXICO Plc, Deals By Market, 2012 to YTD 2018 8
IXICO Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
IXICO Enters into Agreement with Pharma Company 10
Ixico to Raise USD7.5 Million in Private Placement of Shares 11
Ixico Acquires Optimal Medicine for USD2.3 Million 12
IXICO Plc, Key Competitors 13
IXICO Plc, Key Employees 14
IXICO Plc, Subsidiaries 15

List of Figures
IXICO Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
IXICO Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
IXICO Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
IXICO Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
IXICO Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
IXICO Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
IXICO Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
IXICO Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[IXICO Plc (IXI):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CHS Inc.:企業の戦略・SWOT・財務情報
    CHS Inc. - Strategy, SWOT and Corporate Finance Report Summary CHS Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Expeditors International of Washington, Inc.:企業の戦略・SWOT・財務情報
    Expeditors International of Washington, Inc. - Strategy, SWOT and Corporate Finance Report Summary Expeditors International of Washington, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Spectrum Pharmaceuticals Inc (SPPI):製薬・医療:M&Aディール及び事業提携情報
    Summary Spectrum Pharmaceuticals Inc (Spectrum) is a biotechnology company that develops and commercializes a pipeline of late-stage clinical and commercial products with focus on hematology and oncology. The company’s marketed drugs include Fusilev (levoleucovorin); Folotyn (pralatrexate injection) …
  • BB Biotech AG (BION):企業の財務・戦略的SWOT分析
    Summary BB Biotech AG (BB Biotech) operates as a financial service provider that offers biotechnology investments. The company invests in markets that develop new drugs and therapies for use in the treatment of autoimmune and infectious diseases, oncology disorders, cardiovascular diseases, and meta …
  • Aevi Genomic Medicine Inc (GNMX):企業の財務・戦略的SWOT分析
    Summary Aevi Genomic Medicine Inc (Aevi), formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and life-altering diseases.The company provides pipeline products such as AEVI-001 and AEVI-002. Its lead product AEVI-001, is a glut …
  • Interferie S.A.:企業の戦略・SWOT・財務情報
    Interferie S.A. - Strategy, SWOT and Corporate Finance Report Summary Interferie S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • HTC Corporation:戦略・SWOT・企業財務分析
    HTC Corporation - Strategy, SWOT and Corporate Finance Report Summary HTC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Inspire Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Inspire Medical Systems Inc (Inspire) is a medical device company that manufactures and markets healthcare implants. The company provides implanted neurostimulation device. Its product is used for treatment of obstructive sleep apnea. Inspire uses neurostimulation technologies. The company’s …
  • IDACORP, Inc.:企業の戦略・SWOT・財務情報
    IDACORP, Inc. - Strategy, SWOT and Corporate Finance Report Summary IDACORP, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Hero AG:企業の戦略・SWOT・財務分析
    Hero AG - Strategy, SWOT and Corporate Finance Report Summary Hero AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Tokyo Electron Limited:企業の戦略・SWOT・財務情報
    Tokyo Electron Limited - Strategy, SWOT and Corporate Finance Report Summary Tokyo Electron Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Syntel Inc (SYNT):企業の財務・戦略的SWOT分析
    Syntel Inc (SYNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kore Potash Plc (ELM):企業の財務・戦略的SWOT分析
    Summary Kore Potash Plc (Kore Potash), formerly Elemental Minerals Ltd, is a mining company that offers exploration and development of mineral resources. The company offers development of potash project in the Republic of Congo and operates an exploration project in Australia. It also owns and opera …
  • Zafgen Inc (ZFGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Zafgen Inc (Zafgen) is a clinical-stage biopharmaceutical company that develops transformative therapies for patients affected by a range of metabolic diseases. Its pipeline product portfolio includes ZGN-1061, a small molecule MetAP2 inhibitor being developed for patients with type 2 diabet …
  • Linklaters Llp:企業の戦略・SWOT・財務分析
    Linklaters Llp - Strategy, SWOT and Corporate Finance Report Summary Linklaters Llp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Dova Pharmaceuticals Inc (DOVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Dova Pharmaceuticals Inc (Dova), formerly PBM AKX Holdings LLC, is a clinical-stage pharmaceutical company that acquires, develops and commercializes therapies for the treatment of orphan diseases. The company’s lead candidate, Avatrombopag (DOPTELET), a novel, oral thrombopoietin receptor a …
  • Par Pacific Holdings, Inc. (PARR):企業の財務・戦略的SWOT分析
    Par Pacific Holdings, Inc. (PARR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Freehold Royalties Ltd (FRU):石油・ガス:M&Aディール及び事業提携情報
    Summary Freehold Royalties Ltd (Freehold Royalties), formerly Freehold Royalty Trust is an oil and gas company that offers oil and gas operation and financial performance. The company's oil and gas assets generate income from natural gas, crude oil, natural gas liquids and potash deposits. It provid …
  • QIMR Berghofer Medical Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary QIMR Berghofer Medical Research Institute (QIMR), formerly Queensland Institute of Medical Research is a medical research institute that offers education and research programs. The institute offers its research programs in the areas of mental health, cancer, infectious disease, and complex d …
  • Fugro GeoServices Ltd:企業の戦略的SWOT分析
    Fugro GeoServices Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆